| 2005 | | Metabolic demand and renal mass supply affecting the early graft function after living donor kidney transplantation. | 오창권 |
| 2012 | | Multicenter Clinical Investigation for the Safety and Efficacy of Advagrafⓡ (Extended Release Tacrolimus) versus Prografⓡ (Tacrolimus) in De Novo Kidney Recipients after 1 Month of Transplantation: Preliminary Results | 이종훈, 오창권 |
| 2014 | | New predictive marker for hemodialysis vascular access dysfunction. | 원제환, 오창권 |
| 2008 | | Predicting the ideal serum creatinine of kidney transplant recipients by a simple formula based on the balance between metabolic demands of recipients and renal mass supply from donors. | 오창권, 김흥수 |
| 2012 | | Prospective controlled protocol for three months steroid withdrawal with tacrolimus, basiliximab, and mycophenolate mofetil in renal transplant recipients | 오창권, 이종훈 |
| 2018 | | Reduced Tacrolimus Trough Level Is Reflected by Estimated Glomerular Filtration Rate (eGFR) Changes in Stable Renal Transplantation Recipients: Results of the OPTIMUM Phase 3 Randomized Controlled Study | 오창권 |
| 2010 | | Routine Perioperative Antibiotic Prophylaxis in Renal Transplantation: It Makes No Difference for Bacterial Infections | 오창권, 신규태,김흥수, 김세중,김선일 |
| 2006 | | Routine screening for the functional asymmetry of potential kidney donors. | 오창권, 윤석남,이병모, 김세중,김흥수, 신규태 |
| 2014 | | Safety and efficacy of conversion from twice-daily tacrolimus to once-daily tacrolimus one month after transplantation: randomized controlled trial in adult renal transplantation. | 오창권 |
| 2012 | | Safety and Efficacy of the Early Introduction of Everolimus (Certican(R)) with Low Dose of Cyclosporine in de Novo Kidney Recipients after 1 Month of Transplantation (Preliminary Results) | 오창권 |
| 2015 | | Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients. | 오창권 |
| 2010 | | Sirolimus/steroids Maintenance Therapy after Early Cyclosporine Withdrawal: 12-month Efficacy and Safety Results of Multicenter Single Arm Pilot Study in Primary Renal Allograft Recipients in Korea. | 오창권 |
| 2012 | | Successful Sirolimus Treatment of Kaposi’s Sarcoma in Multiple Pulmonary Nodules | 정윤정, 신승수,이종훈, 오창권 |
| 2007 | | Survival analysis of Korean end-stage renal disease patients according to renal replacement therapy in a single center. | 오창권, 신규태,김흥수 |
| 2006 | | The Clinical Significance of Routine Screening for the Renal Functional Asymmetry in Potential Live Kidney Donor | 윤석남, 오창권,이병모, 김세중,김흥수, 신규태 |
| 2007 | | The Effect of Basiliximab on the Incidence of Acute Renal Allograft Rejection within 1 Year Post-Transplantation | 오창권, 김세중,김흥수, 신규태 |
| 2012 | | The impact of A(H1N1)pdm09 infection on renal transplant recipients: a multicenter cohort study | 오창권 |
| 2016 | | Transjugular Access for Endovascular Treatment of Immature Autogenous Arteriovenous Fistulae | 원제환, 오창권,이수형, 심종준,김진우 |
| 1996 | | Treatment of steroid resistant acute rejection after renal transplantation. | 오창권 |
| 2001 | | Uni- and multi-variate analysis of risk factors for early and late hepatic artery thrombosis after liver transplantation. | 오창권 |
